<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Ark Therapeutics Group plc - Google Finance</title>
<description>News for Ark Therapeutics Group plc - Google Finance</description>
<link>http://www.google.co.uk/finance?q=LON:AKT&amp;amp;client=news-rss&amp;amp;ei=Pg-eUeCGHfDq0QHTJw</link>
<image>
<title>News for Ark Therapeutics Group plc - Google Finance</title>
<url>/finance/s/-vLkpqn8pIU/images/logo_uk.gif</url>
<link>http://www.google.co.uk/finance?q=LON:AKT&amp;amp;client=news-rss&amp;amp;ei=Pg-eUeCGHfDq0QHTJw</link>
</image>
<item>
<title>ARK THERAPEUTICS GROUP PLC : - Interim Management Statement</title>
<link>http://www.4-traders.com/ARK-THERAPEUTICS-GROUP-PL-4004579/news/Ark-Therapeutics-Group-plc-Interim-Management-Statement-16868760/</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:43982063962715</guid>
<pubDate>Fri, 17 May 2013 06:38:08 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/ARK-THERAPEUTICS-GROUP-PL-4004579/news/Ark-Therapeutics-Group-plc-Interim-Management-Statement-16868760/&quot; style=&quot;font-size:1.2em&quot;&gt;ARK THERAPEUTICS GROUP PLC : - Interim Management Statement&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;17 May 2013 - Ark Therapeutics Group plc (&amp;quot;Ark&amp;quot; or the &amp;quot;Company&amp;quot;) today publishes its interim management statement for the period from 1 January 2013 to date.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>ARK THERAPEUTICS GROUP PLC : - Final Results</title>
<link>http://www.4-traders.com/ARK-THERAPEUTICS-GROUP-PL-4004579/news/Ark-Therapeutics-Group-plc-Final-Results-16799194/</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:52778138983319</guid>
<pubDate>Tue, 30 Apr 2013 06:20:12 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/ARK-THERAPEUTICS-GROUP-PL-4004579/news/Ark-Therapeutics-Group-plc-Final-Results-16799194/&quot; style=&quot;font-size:1.2em&quot;&gt;ARK THERAPEUTICS GROUP PLC : - Final Results&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 30, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Ark Therapeutics Group plc. Preliminary Announcement - Final results for the year ended 31 December 2012. London, UK, 30 April 2013- Ark Therapeutics Group plc (LSE: AKT) today announces its audited results for the year ended 31 December 2012.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>PURICORE PLC : Board Changes</title>
<link>http://www.4-traders.com/PURICORE-PLC-4006210/news/PuriCore-plc-Board-Changes-16861597/</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://www.4-traders.com/PURICORE-PLC-4006210/news/PuriCore-plc-Board-Changes-16861597/</guid>
<pubDate>Tue, 14 May 2013 19:52:46 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/PURICORE-PLC-4006210/news/PuriCore-plc-Board-Changes-16861597/&quot; style=&quot;font-size:1.2em&quot;&gt;PURICORE PLC : Board Changes&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Mr Spicer is a Non-Executive Director of Aircraft Medical, Stanmore Implants, Ark Therapeutics Group plc, and XCounter AB. He is chair of the UK Department of Health&amp;#39;s Invention for Innovation Funding Panel, a panel member on the UK Health Innovation ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>DIARY - Western European Corporate events from May 17</title>
<link>http://www.reuters.com/article/2013/05/17/diary-weu-earnings-idUSL3N0DY13K20130517</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:43982063965262</guid>
<pubDate>Fri, 17 May 2013 06:42:27 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/article/2013/05/17/diary-weu-earnings-idUSL3N0DY13K20130517&quot; style=&quot;font-size:1.2em&quot;&gt;DIARY - Western European Corporate events from May 17&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;... 17-May GB ARK THERAPEUTICS GROUP PLC Q1 TRADE 17-May GB ALENT PLC Q1 TRADE 17-May GB ALPHA PYRENEES TRUST LTD Q1 TRADE 17-May GB BRAMMER PLC TRADING 17-May GB 6:00 CHESNARA PLC Q1 TRADE 17-May DE ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>DIARY - Western European Corporate events from May 15</title>
<link>http://www.reuters.com/article/2013/05/15/diary-weu-earnings-idUSL3N0DV2TI20130515</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:43982061071322</guid>
<pubDate>Wed, 15 May 2013 06:09:50 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/article/2013/05/15/diary-weu-earnings-idUSL3N0DV2TI20130515&quot; style=&quot;font-size:1.2em&quot;&gt;DIARY - Western European Corporate events from May 15&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 15, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;... 17-May GB ARK THERAPEUTICS GROUP PLC Q1 TRADE 17-May GB ALENT PLC Q1 TRADE 17-May GB ALPHA PYRENEES TRUST LTD Q1 TRADE 17-May GB BRAMMER PLC TRADING 17-May GB CENTAUR MEDIA PLC TRADING 17-May GB 6:00 ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Pharmaceutical Market: Finland, Ireland, Denmark, Belgium, Cuba, Austria ...</title>
<link>http://www.prnewswire.com/news-releases/pharmaceutical-market-finland-ireland-denmark-belgium-cuba-austria--norway-205264371.html</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:52778138273079</guid>
<pubDate>Mon, 29 Apr 2013 18:07:21 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.prnewswire.com/news-releases/pharmaceutical-market-finland-ireland-denmark-belgium-cuba-austria--norway-205264371.html&quot; style=&quot;font-size:1.2em&quot;&gt;Pharmaceutical Market: Finland, Ireland, Denmark, Belgium, Cuba, Austria ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;PR Newswire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 29, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;... followed by Pfizer, Novartis, AstraZeneca and GlaxoSmithKline. In the biologic sector, Biotie Therapies completed its acquisition of Synosia Therapeutics in February 2011, while Ark Therapeutics entered into a formal agreement to divest the ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Ark Therapeutics Group plc Signs Letter Of Intent With EMD Millipore Corporation</title>
<link>http://www.reuters.com/finance/stocks/AKT.L/key-developments/article/2589806</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2589806</guid>
<pubDate>Tue, 14 Aug 2012 06:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/AKT.L/key-developments/article/2589806&quot; style=&quot;font-size:1.2em&quot;&gt;Ark Therapeutics Group plc Signs Letter Of Intent With EMD Millipore Corporation&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Aug 14, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Ark Therapeutics Group plc Signs Master Manufacturing Services Agreement With Europe&amp;#39;s Gene Therapy Companies</title>
<link>http://www.reuters.com/finance/stocks/AKT.L/key-developments/article/2578267</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2578267</guid>
<pubDate>Wed, 25 Jul 2012 06:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/AKT.L/key-developments/article/2578267&quot; style=&quot;font-size:1.2em&quot;&gt;Ark Therapeutics Group plc Signs Master Manufacturing Services Agreement With Europe&amp;#39;s Gene Therapy Companies&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jul 25, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Ark Therapeutics Group plc Announces Appointment Of Chief Executive Officer</title>
<link>http://www.reuters.com/finance/stocks/AKT.L/key-developments/article/2569227</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2569227</guid>
<pubDate>Thu, 05 Jul 2012 06:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/AKT.L/key-developments/article/2569227&quot; style=&quot;font-size:1.2em&quot;&gt;Ark Therapeutics Group plc Announces Appointment Of Chief Executive Officer&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jul 5, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Ark Therapeutics Group plc Receives Notice Of Allowance Of US Patent For EG013</title>
<link>http://www.reuters.com/finance/stocks/AKT.L/key-developments/article/2532501</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2532501</guid>
<pubDate>Wed, 02 May 2012 06:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/AKT.L/key-developments/article/2532501&quot; style=&quot;font-size:1.2em&quot;&gt;Ark Therapeutics Group plc Receives Notice Of Allowance Of US Patent For EG013&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 2, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
